Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John H Growdon

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Journal of Alzheimer'S Disease : JAD|September 6, 2002
Incorporating biomarkers into clinical drug trials in Alzheimer's diseaseJohn H. Growdon
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Commentary on "Diagnosis of Alzheimer's disease: two decades of progress." The NIA's Alzheimer Disease CentersJohn H Growdon
JAMA Neurology|December 9, 2014
Challenges and opportunities in linking brain-based biomarkers to person-specific variation in cognition: pumping up the volumeTrey Hedden, John H Growdon
Archives of Neurology|January 16, 2002
Diagnosing dementia with Lewy bodiesFernando Pompeu, John H Growdon
Nature Medicine|July 11, 2006
Can the immune system fight Alzheimer disease?Bradley T Hyman, John H Growdon
Archives of Neurology|June 15, 2011
Plasma beta-amyloid linked to cognitive declineJohn H Growdon, Bradley T Hyman
Archives of Neurology|August 11, 2010
Sharpen that needleA Zara Herskovits, John H Growdon
Journal of Alzheimer'S Disease : JAD|February 19, 2019
Is Alzheimer's Disease Risk Modifiable?Alberto Serrano-Pozo, John H Growdon
JAMA Neurology|November 27, 2013
APOE genotype and brain developmentJohn H Growdon, Bradley T Hyman
JAMA Neurology|February 3, 2016
The Human Alzheimer Disease Project: Answering the CallSteven T DeKosky, John H Growdon
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Journal of Alzheimer'S Disease : JAD|September 6, 2002
Incorporating biomarkers into clinical drug trials in Alzheimer's diseaseJohn H. Growdon
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Commentary on "Diagnosis of Alzheimer's disease: two decades of progress." The NIA's Alzheimer Disease CentersJohn H Growdon
JAMA Neurology|December 9, 2014
Challenges and opportunities in linking brain-based biomarkers to person-specific variation in cognition: pumping up the volumeTrey Hedden, John H Growdon
Archives of Neurology|January 16, 2002
Diagnosing dementia with Lewy bodiesFernando Pompeu, John H Growdon
Nature Medicine|July 11, 2006
Can the immune system fight Alzheimer disease?Bradley T Hyman, John H Growdon
Archives of Neurology|June 15, 2011
Plasma beta-amyloid linked to cognitive declineJohn H Growdon, Bradley T Hyman
Archives of Neurology|August 11, 2010
Sharpen that needleA Zara Herskovits, John H Growdon
Journal of Alzheimer'S Disease : JAD|February 19, 2019
Is Alzheimer's Disease Risk Modifiable?Alberto Serrano-Pozo, John H Growdon
JAMA Neurology|November 27, 2013
APOE genotype and brain developmentJohn H Growdon, Bradley T Hyman
JAMA Neurology|February 3, 2016
The Human Alzheimer Disease Project: Answering the CallSteven T DeKosky, John H Growdon
Pageof 8